effect of ayurvedic formulation in high blood pressure
Phase 2
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2018/10/016005
- Lead Sponsor
- ational institute of ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients who newly diagnosed as E.H.T (within 1-3 month duration) will be selected.
2.Mild to moderate grade patients of hypertension as per 7th JNC & WHO criteria will be include.
3.Isolated grade-1 Systolic or Diastolic hypertension
Exclusion Criteria
1]Secondary hypertension.
2] Renal diseases, Diabetic Mellitus.
3] Pregnancy induced hypertension.
4] Drugs like Oral Contraceptive Pills, steroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess role of NIA/DG/2015/01 formulation in Newly Diagnosed (1-3mnth) Stage-1 Essential Hypertension.Timepoint: To assess role of NIA/DG/2015/01 formulation in Newly Diagnosed (1-3mnth) Stage-1 Essential Hypertension.
- Secondary Outcome Measures
Name Time Method To assess role of ayurevidic formulation in all stage of hypertensionTimepoint: 6 months